These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1848168)
41. Indocyanine green. Its use as an early indicator of hepatic dysfunction following injury in man. Gottlieb ME; Stratton HH; Newell JC; Shah DM Arch Surg; 1984 Mar; 119(3):264-8. PubMed ID: 6696619 [TBL] [Abstract][Full Text] [Related]
42. Effects of single-dose and short-term oral nifedipine on indocyanine green clearance as assessed by spectrophotometry and high performance liquid chromatography. Soons PA; Kroon JM; Breimer DD J Clin Pharmacol; 1990 Aug; 30(8):693-8. PubMed ID: 2401748 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis. Stauber RE; Wagner D; Stadlbauer V; Palma S; Gurakuqi G; Kniepeiss D; Iberer F; Smolle KH; Haas J; Trauner M Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329 [TBL] [Abstract][Full Text] [Related]
44. Indocyanine green kinetics characterize blood volume and flow distribution and their alteration by propranolol. Niemann CU; Henthorn TK; Krejcie TC; Shanks CA; Enders-Klein C; Avram MJ Clin Pharmacol Ther; 2000 Apr; 67(4):342-50. PubMed ID: 10801242 [TBL] [Abstract][Full Text] [Related]
45. Effect of portacaval shunt on drug disposition in patients with cirrhosis. Pomier-Layrargues G; Huet PM; Villeneuve JP; Marleau D Gastroenterology; 1986 Jul; 91(1):163-7. PubMed ID: 3710065 [TBL] [Abstract][Full Text] [Related]
46. Hepatic parenchymal cell volume and the indocyanine green tolerance test. Hashimoto M; Watanabe G J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825 [TBL] [Abstract][Full Text] [Related]
47. Indocyanine green clearance after cardiac surgery: the impact of cardiopulmonary bypass. Möhnle P; Kilger E; Adnan L; Beiras-Fernandez A; Vicol C; Weis F Perfusion; 2012 Jul; 27(4):292-9. PubMed ID: 22354895 [TBL] [Abstract][Full Text] [Related]
48. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests. Forestier J; Dumortier J; Guillaud O; Ecochard M; Roman S; Boillot O; Lutringer D; Scoazec JY; Subtil F; Mion F Eur J Gastroenterol Hepatol; 2010 May; 22(5):532-40. PubMed ID: 20164779 [TBL] [Abstract][Full Text] [Related]
49. Indocyanine green-sulfobromophthalein pharmacokinetics for diagnosing primary biliary cirrhosis and assessing histological severity. Vaubourdolle M; Gufflet V; Chazouillères O; Giboudeau J; Poupon R Clin Chem; 1991 Oct; 37(10 Pt 1):1688-90. PubMed ID: 1914166 [TBL] [Abstract][Full Text] [Related]
50. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green. Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351 [TBL] [Abstract][Full Text] [Related]
51. Verapamil pharmacokinetics and liver function in patients with cirrhosis. Finucci GF; Padrini R; Piovan D; Melica E; Merkel C; Gatta A; Zuin R Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854 [TBL] [Abstract][Full Text] [Related]
53. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Zeeh J; Lange H; Bosch J; Pohl S; Loesgen H; Eggers R; Navasa M; Chesta J; Bircher J Gastroenterology; 1988 Sep; 95(3):749-59. PubMed ID: 3396820 [TBL] [Abstract][Full Text] [Related]
54. Effects of hepatic ischaemia/reperfusion injury in a rabbit model of Indocyanine Green clearance. Seifalian AM; El-Desoky H; Delpy DT; Davidson BR Clin Sci (Lond); 2002 May; 102(5):579-86. PubMed ID: 11980578 [TBL] [Abstract][Full Text] [Related]
55. [The effect of the method of detecting indocyanine green (HPLC, spectrophotometry) on the determination of pharmacokinetic parameters]. Aubrecht J; Perlík F Cesk Farm; 1990 Jun; 39(4):155-7. PubMed ID: 2393913 [TBL] [Abstract][Full Text] [Related]
56. Effects of anesthetic agents and abdominal surgery on liver blood flow. Cowan RE; Jackson BT; Grainger SL; Thompson RP Hepatology; 1991 Dec; 14(6):1161-6. PubMed ID: 1959866 [TBL] [Abstract][Full Text] [Related]
57. Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects. Andersen V; Sonne J; Larsen S Scand J Gastroenterol; 1999 Aug; 34(8):813-7. PubMed ID: 10499483 [TBL] [Abstract][Full Text] [Related]
58. Comparison of indocyanine green clearance with Child's-Pugh score and hepatic histology: a multivariate analysis. Mukherjee S; Rogers MA; Buniak B Hepatogastroenterology; 2006; 53(67):120-3. PubMed ID: 16506389 [TBL] [Abstract][Full Text] [Related]
59. Effect of cimetidine on the hepatic extraction of indocyanine green, the portal pressure and the systemic circulation in patients with cirrhosis of the liver. Herz R; Rössle M; Bonzel T; Keller E; Gerok W Klin Wochenschr; 1984 Aug; 62(16):759-64. PubMed ID: 6482311 [TBL] [Abstract][Full Text] [Related]
60. Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Kimura S; Yoshioka T; Shibuya M; Sakano T; Tanaka R; Matsuyama S Crit Care Med; 2001 Jun; 29(6):1159-63. PubMed ID: 11395594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]